Bristol-Myers Squibb Named Top 10 Company for Diversity & Inclusion

In the 2018 Thomson Reuters’ Diversity & Inclusion Index

Sep 13, 2018 11:45 AM ET

We’re honored to be in the top 10 of Thomson Reuters’ 2018 Diversity & Inclusion (D&I) Index. Global Diversity & Inclusion is a key priority for our company and we are committed to creating a culture that empowers our people to share their unique perspectives and pursue innovative ideas to bring transformational medicines to patients.

Continue reading about Bristol-Myers Squibb's commitment to Global D&I.

Bristol-Myers Squibb Named Top 10 Company for Diversity & Inclusion

In the 2018 Thomson Reuters’ Diversity & Inclusion Index

More from Bristol Myers Squibb Company

Bristol Myers Squibb Promotes Health Equity with 100 Percent of Marketed Products Now Supported by Access Plans

Bristol Myers Squibb's Commitment to Environment, Social and Governance: Our Progress & Aspirational Goals

Bristol Myers Squibb Reaches Major Milestone in Environmental Sustainability

BMS Named 2024 Best Place to Work for Disability Inclusion in US, UK and Brazil by the Disability Equality Index®

Bristol Myers Squibb Named to Dow Jones Sustainability Index North America

ASPIRE: Our Commitment To Address Health Inequities in Low- and Middle-Income Countries

Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries

Building a Better Future: Bristol Myers Squibb 2023 ESG Report